ETOPOPHOS is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Etoposide Phosphate.
| Product ID | 0015-3404_23c5d977-f8be-4f5b-b810-9a0ec0866925 | 
| NDC | 0015-3404 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | ETOPOPHOS | 
| Generic Name | Etoposide Phosphate | 
| Dosage Form | Injection, Powder, Lyophilized, For Solution | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2009-06-01 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA020457 | 
| Labeler Name | E.R. Squibb & Sons, L.L.C. | 
| Substance Name | ETOPOSIDE PHOSPHATE | 
| Active Ingredient Strength | 100 mg/1 | 
| Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2009-06-01 | 
| Marketing End Date | 2021-04-30 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA020457 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2009-06-01 | 
| Marketing End Date | 2021-04-30 | 
| Ingredient | Strength | 
|---|---|
| ETOPOSIDE PHOSPHATE | 100 mg/1 | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0015-3404 | ETOPOPHOS | etoposide phosphate | 
| 61269-410 | ETOPOPHOS | etoposide phosphate | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  ETOPOPHOS  74179774  1757537 Live/Registered | CHEPLAPHARM ARZNEIMITTEL GMBH 1991-06-25 |